PKR and GCN2 stress kinases promote an ER stress-independent eIF2α phosphorylation responsible for calreticulin exposure in melanoma cells

Paola Giglio, Mara Gagliardi, Nicola Tumino, Fernanda Antunes, Soraya Smaili, Diego Cotella, Claudio Santoro, Roberta Bernardini, Maurizio Mattei, Mauro Piacentini, Marco Corazzari

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The immunogenic cell death (ICD) process represents a novel therapeutic approach to treat tumours, in which cytotoxic compounds promote both cancer cell death and the emission of damage-associated molecular patterns (DAMPs) from dying cells, to activate the immune system against the malignancy. Therefore, we explored the possibility to stimulate the key molecular players with a pivotal role in the execution of the ICD program in melanoma cells. To this aim, we used the pro-ICD agents mitoxantrone and doxorubicin and found that both agents could induce cell death and stimulate the release/exposure of the strictly required DAMPs in melanoma cells: i) calreticulin (CRT) exposure on the cell membrane; ii) ATP secretion; iii) type I IFNs gene up-regulation and iv) HMGB1 secretion, highlighting no interference by oncogenic BRAF. Importantly, although the ER stress-related PERK activation has been linked to CRT externalization, through the phosphorylation of eIF2α, we found that this stress pathway together with PERK were not involved in melanoma cells. Notably, we identified PKR and GCN2 as key mediators of eIF2α phosphorylation, facilitating the translocation of CTR on melanoma cells surface, under pro-ICD drugs stimulation. Therefore, our data indicate that pro-ICD drugs are able to stimulate the production/release of DAMPs in melanoma cells at least in vitro, indicating in this approach a potential new valuable therapeutic strategy to treat human skin melanoma malignancy.

Original languageEnglish
JournalOncoImmunology
DOIs
Publication statusPublished - May 28 2018

Fingerprint

Calreticulin
Melanoma
Cell Death
Phosphotransferases
Phosphorylation
Neoplasms
HMGB1 Protein
Mitoxantrone
Pharmaceutical Preparations
Doxorubicin
Immune System
Up-Regulation
Adenosine Triphosphate
Cell Membrane
Skin
Therapeutics

Keywords

  • BRAF
  • ecto-CRT
  • eIF2α
  • ER stress
  • GCN2
  • melanoma
  • PKR

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Oncology

Cite this

PKR and GCN2 stress kinases promote an ER stress-independent eIF2α phosphorylation responsible for calreticulin exposure in melanoma cells. / Giglio, Paola; Gagliardi, Mara; Tumino, Nicola; Antunes, Fernanda; Smaili, Soraya; Cotella, Diego; Santoro, Claudio; Bernardini, Roberta; Mattei, Maurizio; Piacentini, Mauro; Corazzari, Marco.

In: OncoImmunology, 28.05.2018.

Research output: Contribution to journalArticle

Giglio, Paola ; Gagliardi, Mara ; Tumino, Nicola ; Antunes, Fernanda ; Smaili, Soraya ; Cotella, Diego ; Santoro, Claudio ; Bernardini, Roberta ; Mattei, Maurizio ; Piacentini, Mauro ; Corazzari, Marco. / PKR and GCN2 stress kinases promote an ER stress-independent eIF2α phosphorylation responsible for calreticulin exposure in melanoma cells. In: OncoImmunology. 2018.
@article{a65fc25490ee4d79a3c7db7ac474a044,
title = "PKR and GCN2 stress kinases promote an ER stress-independent eIF2α phosphorylation responsible for calreticulin exposure in melanoma cells",
abstract = "The immunogenic cell death (ICD) process represents a novel therapeutic approach to treat tumours, in which cytotoxic compounds promote both cancer cell death and the emission of damage-associated molecular patterns (DAMPs) from dying cells, to activate the immune system against the malignancy. Therefore, we explored the possibility to stimulate the key molecular players with a pivotal role in the execution of the ICD program in melanoma cells. To this aim, we used the pro-ICD agents mitoxantrone and doxorubicin and found that both agents could induce cell death and stimulate the release/exposure of the strictly required DAMPs in melanoma cells: i) calreticulin (CRT) exposure on the cell membrane; ii) ATP secretion; iii) type I IFNs gene up-regulation and iv) HMGB1 secretion, highlighting no interference by oncogenic BRAF. Importantly, although the ER stress-related PERK activation has been linked to CRT externalization, through the phosphorylation of eIF2α, we found that this stress pathway together with PERK were not involved in melanoma cells. Notably, we identified PKR and GCN2 as key mediators of eIF2α phosphorylation, facilitating the translocation of CTR on melanoma cells surface, under pro-ICD drugs stimulation. Therefore, our data indicate that pro-ICD drugs are able to stimulate the production/release of DAMPs in melanoma cells at least in vitro, indicating in this approach a potential new valuable therapeutic strategy to treat human skin melanoma malignancy.",
keywords = "BRAF, ecto-CRT, eIF2α, ER stress, GCN2, melanoma, PKR",
author = "Paola Giglio and Mara Gagliardi and Nicola Tumino and Fernanda Antunes and Soraya Smaili and Diego Cotella and Claudio Santoro and Roberta Bernardini and Maurizio Mattei and Mauro Piacentini and Marco Corazzari",
year = "2018",
month = "5",
day = "28",
doi = "10.1080/2162402X.2018.1466765",
language = "English",
journal = "OncoImmunology",
issn = "2162-4011",
publisher = "Taylor and Francis Inc.",

}

TY - JOUR

T1 - PKR and GCN2 stress kinases promote an ER stress-independent eIF2α phosphorylation responsible for calreticulin exposure in melanoma cells

AU - Giglio, Paola

AU - Gagliardi, Mara

AU - Tumino, Nicola

AU - Antunes, Fernanda

AU - Smaili, Soraya

AU - Cotella, Diego

AU - Santoro, Claudio

AU - Bernardini, Roberta

AU - Mattei, Maurizio

AU - Piacentini, Mauro

AU - Corazzari, Marco

PY - 2018/5/28

Y1 - 2018/5/28

N2 - The immunogenic cell death (ICD) process represents a novel therapeutic approach to treat tumours, in which cytotoxic compounds promote both cancer cell death and the emission of damage-associated molecular patterns (DAMPs) from dying cells, to activate the immune system against the malignancy. Therefore, we explored the possibility to stimulate the key molecular players with a pivotal role in the execution of the ICD program in melanoma cells. To this aim, we used the pro-ICD agents mitoxantrone and doxorubicin and found that both agents could induce cell death and stimulate the release/exposure of the strictly required DAMPs in melanoma cells: i) calreticulin (CRT) exposure on the cell membrane; ii) ATP secretion; iii) type I IFNs gene up-regulation and iv) HMGB1 secretion, highlighting no interference by oncogenic BRAF. Importantly, although the ER stress-related PERK activation has been linked to CRT externalization, through the phosphorylation of eIF2α, we found that this stress pathway together with PERK were not involved in melanoma cells. Notably, we identified PKR and GCN2 as key mediators of eIF2α phosphorylation, facilitating the translocation of CTR on melanoma cells surface, under pro-ICD drugs stimulation. Therefore, our data indicate that pro-ICD drugs are able to stimulate the production/release of DAMPs in melanoma cells at least in vitro, indicating in this approach a potential new valuable therapeutic strategy to treat human skin melanoma malignancy.

AB - The immunogenic cell death (ICD) process represents a novel therapeutic approach to treat tumours, in which cytotoxic compounds promote both cancer cell death and the emission of damage-associated molecular patterns (DAMPs) from dying cells, to activate the immune system against the malignancy. Therefore, we explored the possibility to stimulate the key molecular players with a pivotal role in the execution of the ICD program in melanoma cells. To this aim, we used the pro-ICD agents mitoxantrone and doxorubicin and found that both agents could induce cell death and stimulate the release/exposure of the strictly required DAMPs in melanoma cells: i) calreticulin (CRT) exposure on the cell membrane; ii) ATP secretion; iii) type I IFNs gene up-regulation and iv) HMGB1 secretion, highlighting no interference by oncogenic BRAF. Importantly, although the ER stress-related PERK activation has been linked to CRT externalization, through the phosphorylation of eIF2α, we found that this stress pathway together with PERK were not involved in melanoma cells. Notably, we identified PKR and GCN2 as key mediators of eIF2α phosphorylation, facilitating the translocation of CTR on melanoma cells surface, under pro-ICD drugs stimulation. Therefore, our data indicate that pro-ICD drugs are able to stimulate the production/release of DAMPs in melanoma cells at least in vitro, indicating in this approach a potential new valuable therapeutic strategy to treat human skin melanoma malignancy.

KW - BRAF

KW - ecto-CRT

KW - eIF2α

KW - ER stress

KW - GCN2

KW - melanoma

KW - PKR

UR - http://www.scopus.com/inward/record.url?scp=85047901247&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047901247&partnerID=8YFLogxK

U2 - 10.1080/2162402X.2018.1466765

DO - 10.1080/2162402X.2018.1466765

M3 - Article

AN - SCOPUS:85047901247

JO - OncoImmunology

JF - OncoImmunology

SN - 2162-4011

ER -